Objective: Older adults have heterogeneous aging rates. Here, we explored the impact of biological age (BA) and accelerated aging on frailty in community-dwelling older adults.
Methods: We assessed 735 community-dwelling older adults from the Coyocan Cohort. BA was measured using AnthropoAge, accelerated aging with AnthropoAgeAccel, and frailty using both Fried's phenotype and the frailty index. We explored the association of BA and accelerated aging (AnthropoAgeAccel ≥0) with frailty at baseline and characterized the impact of both on body composition and physical function. We also explored accelerated aging as a risk factor for frailty progression after 3-years of follow-up.
Results: Older adults with accelerated aging have higher frailty prevalence and indices, lower handgrip strength and gait speed. AnthropoAgeAccel was associated with higher frailty indices (β=0.0053, 95%CI 0.0027-0.0079), and increased odds of frailty at baseline (OR 1.16, 95%CI 1.09-1.25). We observed a sexual dimorphism in body composition and physical function linked to accelerated aging in non-frail participants; however, this dimorphism was absent in pre-frail/frail participants. Accelerated aging at baseline was associated with higher risk of frailty progression over time (OR 1.74, 95%CI 1.11-2.75).
Conclusions: Despite being intertwined, biological accelerated aging is largely independent of frailty in community-dwelling older adults.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370533 | PMC |
| http://dx.doi.org/10.1101/2024.08.20.24312308 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Aging through the lens of mitochondrial DNA mutations and inheritance paradoxes.
Biogerontology
December 2024
Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Mitochondrial DNA encodes essential components of the respiratory chain complexes, serving as the foundation of mitochondrial respiratory function. Mutations in mtDNA primarily impair energy metabolism, exerting far-reaching effects on cellular physiology, particularly in the context of aging. The intrinsic vulnerability of mtDNA is increasingly recognized as a key driver in the initiation of aging and the progression of its related diseases.
View Article and Find Full Text PDFHigh-Performance Fluorine-Lean Thin Aromatic Hydrocarbon Membranes Based on Polyvinylidene Fluoride for Hydrogen Fuel Cells.
Membranes (Basel)
December 2024
PSI Center for Energy and Environmental Sciences, 5232 Villigen PSI, Switzerland.
The impeding ban on per- and polyfluoroalkyl substances (PFAS) prompted researchers to focus on hydrocarbon-based materials as constituents of next-generation proton exchange membranes (PEMs) for polymer electrolyte fuel cells (PEFCs). Here, we report on the fuel cell performance and durability of fluorine-lean PEMs prepared by the post-sulfonation of co-grafted α-methylstyrene (AMS) and 2-methylene glutaronitrile (MGN) monomers into preirradiated 12 µm polyvinylidene fluoride (PVDF) base film. The membranes were subjected to two distinctly different accelerated stress test (AST) protocols performed at open-circuit voltage (OCV): the US Department of Energy-similar chemical AST (90 °C, 30% relative humidity (RH), H/air, 1 bar), developed originally for perfluoroalkylsulfonic acid (PFSA) membranes, and the high relative humidity AST (80 °C, 100% RH, H/O, 2.
View Article and Find Full Text PDFMetabolic Aging as an Increased Risk for Chronic Obstructive Pulmonary Disease.
Metabolites
November 2024
Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Background/objectives: Both aging and chronic obstructive pulmonary disease (COPD) are strongly associated with changes in the metabolome; however, it is unknown whether there are common aging/COPD metabolomic signatures and if accelerated aging is associated with COPD.
Methods: Plasma from 5704 subjects from the Genetic Epidemiology of COPD study (COPDGene) and 2449 subjects from Subpopulations and intermediate outcome measures in COPD study (SPIROMICS) were profiled using the Metabolon global metabolomics platform (1013 annotated metabolites). Post-bronchodilator spirometry measures of airflow obstruction (forced expiratory volume at one second (FEV)/forced vital capacity (FVC) < 0.
Spotlight on the Mechanism of Action of Semaglutide.
Curr Issues Mol Biol
December 2024
1st Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece.
Initially intended to control blood glucose levels in patients with type 2 diabetes, semaglutide, a potent glucagon-like peptide 1 analogue, has been established as an effective weight loss treatment by controlling appetite. Integrating the latest clinical trials, semaglutide in patients with or without diabetes presents significant therapeutic efficacy in ameliorating cardiometabolic risk factors and physical functioning, independent of body weight reduction. Semaglutide may modulate adipose tissue browning, which enhances human metabolism and exhibits possible benefits in skeletal muscle degeneration, accelerated by obesity and ageing.
View Article and Find Full Text PDFP300 Latency with Memory Performance: A Promising Biomarker for Preclinical Stages of Alzheimer's Disease.
Biosensors (Basel)
December 2024
Biomedical Science and Engineering Department, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
Detecting and tracking the preclinical stages of Alzheimer's disease (AD) is now of particular interest due to the aging of the world's population. AD is the most common cause of dementia, affecting the daily lives of those afflicted. Approaches in development can accelerate the evaluation of the preclinical stages of AD and facilitate early treatment and the prevention of symptom progression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!